Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

A Khan, HA Warner, WA Brown - Archives of General Psychiatry, 2000 - jamanetwork.com
The assumption that depressed patients who are assigned to placebo in antidepressant
clinical trials are exposed to substantial morbidity and mortality is not based on research …

[引用][C] Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the Food and Drug Administration database

A KHAN, HA WARNER… - Archives of general …, 2000 - pascal-francis.inist.fr
Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical
trials : An analysis of the Food and Drug Administration database CNRS Inist Pascal-Francis …

[引用][C] Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

A KHAN - Arch Gen Psychiatry, 2000 - cir.nii.ac.jp
Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical
trials: an analysis of the Food and Drug Administration database | CiNii Research CiNii 国立 …

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

A Khan, HA Warner, WA Brown - Archives of general psychiatry, 2000 - safetylit.org
The assumption that depressed patients who are assigned to placebo in antidepressant
clinical trials are exposed to substantial morbidity and mortality is not based on research …

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the Food and Drug Administration database.

A Khan, HA Warner, WA Brown - Archives of General Psychiatry, 2000 - psycnet.apa.org
In an examination of the Food and Drug Administration database for antidepressants
approved from January 1, 1987, through December 31, 1997, the authors hypothesized that …

[引用][C] Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant Clinical Trials: An Analysis of the Food and Drug Administration …

A Khan, HA Warner, WA Brown - Archives of …, 2000 - repository.library.georgetown.edu
Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant
Clinical Trials: An Analysis of the Food and Drug Administration Database Toggle …

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

A Khan, HA Warner, WA Brown - Archives of general …, 2000 - pubmed.ncbi.nlm.nih.gov
The assumption that depressed patients who are assigned to placebo in antidepressant
clinical trials are exposed to substantial morbidity and mortality is not based on research …

[PDF][PDF] Symptom Reduction and Suicide Risk

A Khan, HA Warner, WA Brown - Arch Gen Psychiatry, 2000 - researchgate.net
Arif Khan, MD; Heather A. Warner, MA; Walter A. Brown, MD he assumption that depressed
patients who are assigned to placebo in antidepressant clinical trials are exposed to …

[PDF][PDF] Symptom Reduction and Suicide Risk

A Khan, HA Warner, WA Brown - Arch Gen Psychiatry, 2000 - researchgate.net
Arif Khan, MD; Heather A. Warner, MA; Walter A. Brown, MD he assumption that depressed
patients who are assigned to placebo in antidepressant clinical trials are exposed to …

[引用][C] Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the Food and Drug Administration database

A KHAN, HA WARNER… - Archives of general …, 2000 - American Medical Association